Actively Recruiting
Effect of Prednisolone Treatment on Uterine Natural Killer Cells
Led by Chinese University of Hong Kong · Updated on 2025-03-21
84
Participants Needed
1
Research Sites
456 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to investigate the role of uNK cells and the association with prednisolone.
CONDITIONS
Official Title
Effect of Prednisolone Treatment on Uterine Natural Killer Cells
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women with a history of 3 or more consecutive miscarriages
- Women younger than 40 years old
You will not qualify if you...
- Allergy to prednisolone
- Women who have any uterine anomaly
- Antiphospholipid syndrome
- Hydrosalpinx
- Thrombophilia
- Abnormal thyroid function tests
- Women with diabetes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
Research Team
S
Stacey Wong, BSc
CONTACT
P
Pui Wah Jacqueline Chung, MBBS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here